Guide for Authors


  • The editorial board of the Journal of Medical Imaging and Radiation Sciences (JMIRS) welcomes the submission of manuscripts devoted to all fields of diagnostic imaging and radiation therapies, including nuclear medicine, radiation therapy, magnetic resonance, radiological technology, mammography, interventional radiography, dosimetry, computed tomography, pharmacology and medical ethics. The JMIRS disseminates recent research, new technology and techniques, professional practices and other relevant knowledge that helps medical radiation technologists advance quality and innovation in patient care.

    Each article submitted for publication in JMIRS is forwarded for review to two peer reviewers. The review process is double blind, meaning that both the author and the reviewer will remain anonymous throughout the process. The purpose of the review process is to benefit from the reviewers' knowledge and experience, to gain the reviewers' critical assessment of the article, and to provide concrete feedback to the contributor(s). The review process helps the editorial board in making decisions about articles for publication, and also guides contributors in strengthening their professional writing.

    Manuscripts and materials are received by the JMIRS with the understanding that:

    1. They have not been published or are under consideration for publication in whole or in any significant part elsewhere, in print or electronic format (see Copyright section).
    2. If excerpts, tables or figures from other copyrighted works are included, the author(s) must obtain written permission (see Permissions section).
    3. Publication has been approved by all authors, and all persons designated as authors qualify for authorship (see Authorship section).
    4. Each author has no financial interest in the material or, if so, there is an attached statement noting potential or real conflict of interest (See Conflict of Interest section).
    5. The manuscript complies with the International Committee of Medical Journal Editors' Uniform Requirements for Manuscripts (see Preparation of Manuscripts section).

    Author Information - Overview
    Electronic Submission
    Copyright Act
    Manuscript preparation
    i. Title Page
    ii. Cover Letter
    iii. Abstract
    iv. Introduction
    v. Materials / Methods
    vi. Results
    vii. Discussion / Conclusion
    viii. Figures, Legends and Tables
    ix. References
    x. Biographical Notes / Acknowledgements
    Permissions
    Conflict of Interest
    Statement of Informed Consent
    Ethical Considerations
    Authorship
    Statisticsl
    Language / Spelling
    Drug names / Instrumentation names
    Colour

    Electronic Submission
    Manuscripts must be submitted via the Elsevier Editorial System (EES) website for this journal; go to http://ees.elsevier.com/jmirs/ and select "Submit Paper". You will be guided stepwise through the creation and uploading of the various files and data. Once the uploading is done, the system automatically generates an electronic (PDF) proof, which is then used for peer reviewing. All correspondence regarding submitted manuscripts will be handled via e-mail through EES. Please note: the Elsevier website offers a tutorial section for authors, as well as 24-hour phone or email assistance should you have any difficulty navigating the system. You can also contact the CAMRT office at editorialoffice@camrt.ca.

    Copyright Act (R.S., c55, s.1)
    A signed copyright form should be enclosed with all materials (available here). We cannot publish your article without this signed agreement. Please note that:


    • The copyright form stipulates that the material submitted to JMIRS is original and has not been submitted to another publication for concurrent consideration.
    • If one has a concern or is in question concerning prior publication, please submit the title page and abstract with submission of materials.
    • Acceptance of the agreement will ensure the widest possible dissemination of information.
    • For details on copyright policy, please refer to Copyright Information at http://www.elsevier.com/authors.
    • As an author, you (or your employer or institution) retain certain rights; for details refer to: http://www.elsevier.com/authorsrights.
    • If the manuscript is not published in the JMIRS, this agreement will not take effect.

    Preparation of Manuscripts
    Before you submit your manuscript, please ensure that the following sections are included:

    Title page: The title page should include a concise but informative title; a complete byline, including each author's full name and highest earned academic degree(s); each author's complete affiliation(s), including department(s), institution(s), city, state, and country; and the name and complete mailing address, phone number, fax number and e-mail address of the corresponding author (to whom all correspondence and reprint requests will be directed).

    Cover Letter: Any potential conflict of interest should be disclosed in the cover letter. Sources of outside support for research, including funding, equipment, and drugs, must be named in the cover letter. If an author has no conflicts of interest to declare, this must be explicitly stated. Authors should contact the Editorial Office with questions or concerns, but should err on the side of inclusion when in doubt. Manuscripts that fail to include the complete statements of all authors upon submission will be returned to the corresponding author and will delay the processing and evaluation of the manuscript.

    Abstract: The abstract should reflect the content of the article and include the purpose of the study, the experimental design, the most important results and an interpretation of the data, including the conclusion and any implications derived from the results.

    Introduction: State the purpose of the article and summarize the rationale for the study or observation. Give only strictly pertinent references and do not include data or conclusions from the work being reported.

    Materials / Methods: Case reports should contain a concise description of methodology, data and correlative studies. Manuscripts containing the results of experimental studies on human participants must disclose in the first paragraph of the Materials and Methods section whether informed consent was obtained from patients in the study after the nature of the procedure had been fully explained. A statement must be added indicating that an institutional review committee approved the study (with the date of approval). Describe clearly your selection of the observational or experimental subjects (including controls). The guiding principle should be clarity about how and why a study was done in a particular way. For example, authors should explain why only subjects of certain ages were included or why women were excluded. Identify the methods, apparatus and procedures in sufficient detail to allow other workers to reproduce the results. Give references to established methods, including statistical methods; provide references and brief descriptions for methods that have been published but are not well known; describe new or substantially modified methods, give reasons for using them and evaluate their limitations. Identify precisely all drugs and chemicals used, including generic name(s), dosage(s), and route(s) of administration. Methods should not be included in the Results section or figure legends.

    Results: Present your results in logical sequence in the text, tables and illustrations. Do not repeat in the texts all the data in the tables or illustrations; emphasize or summarize only important observations.

    Discussion/Conclusion: Emphasize the new and important aspects of the study and the conclusions that follow from them. Include the implications of the findings and their limitations, including implications for future research. Relate the observations to other relevant studies. Link the conclusions with the goals of the study, but avoid unqualified statements and conclusions not completely supported by the data. In particular, avoid making statements unless the manuscript contains data to support the claim. Recommendations, when appropriate, may be included.

    Figures, Legends & Tables should be self-explanatory and should supplement, not duplicate the text. Each table must be cited in consecutive numerical order in the text. Place explanatory matter in footnotes, not in the heading. Expand in the footnote all non-standard abbreviations used in each table. For footnotes, identify statistical measures of variations, such as standard deviation and standard error of the mean. If data from another published source are used, obtain written permission from the publisher of the original source and acknowledge fully. If data from an unpublished source are used, obtain permission from the principal investigator, and acknowledge fully. Illustrations should clarify and augment the text. Because imaging is a major aspect of medical radiation technology, the selection of sharp, high-quality halftone illustrations is of paramount importance. Titles and detailed explanations should be incorporated into the legend and not placed on the illustration itself. When necessary for clarity, arrows or letter designations may be affixed to the illustration. All patient information and institutional identifying data must be removed from illustrations. Each illustration must be numbered and cited in consecutive order in the text. Complete, explanatory and descriptive legends must be provided for all figures. A separate list of figure captions must be included in the main body of your paper, following the references. The legends must correspond to the consecutively numbered figures. Figure legends should be brief, specific and contain an explanation for all symbols and abbreviations given in the figure. Acknowledgement of previously published material should be given in the legend, and the source should be included in the References section.

    References: All references to other papers, books, etc., should be given at the end of the paper. They should be consecutively numbered as they appear in the text (not alphabetical). In the text, references should appear in square brackets, e.g., [2, 12-15]. References cited only in tables or in legends should be numbered in accordance with the sequence established by the first identification in the text of the particular table or illustration. Reference style should adhere to the American Medical Association Manual of Style. All bibliographic information must be complete and accurate. The author is responsible for the accuracy of all references. The format of references should include:

    1. Names and initials of all authors when six or fewer. Otherwise list only the first three and add et al.
    2. Full title of the article or chapter.
    3. a) For journals: Name of the journal (abbreviated as in Index Medicus), year of publication, volume number, and first and last page numbers.b) For books: Title of the book preceded by 'In:'; names and initials (same rules as for authors), 'editor(s):'; Publisher's name and city, year of publication; first and last relevant page numbers.

    Biographical Notes/Acknowledgements: Biographical notes about the author(s) should be written in the third person. All contributors who do not meet the criteria for authorship as defined in the Authorship section below should be listed in an acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, writing assistance or a department chair who provided only general support. Authors should disclose whether they had any writing assistance and identify the entity that paid for this assistance (see Conflict of Interest section). Because readers may infer endorsement of the data and conclusions, all persons acknowledged must give written permission for their contribution to be noted in print. It is the corresponding author's responsibility to obtain written permission.

    Permissions
    It is the author's responsibility to obtain written permission for any borrowed, modified or adapted text, tables or figures from the copyright owner (usually the original publisher). If text material totaling 250 to 300 words, or any tables, are borrowed verbatim from published sources, written permission is required from both publisher and author. With shorter quotations, it is sufficient to add a bibliographic credit. Permission letters for reproduced text or illustration must accompany the manuscript. If you have been unable to obtain permission, please point this out.


    Conflict of Interest
    The potential for conflict of interest exists when an author, the author's institution, reviewer or editor has financial relationships (such as employment, consultancy, stock ownership, honoraria and paid expert testimony) that may inappropriately influence his or her actions. Other forms of conflict of interest include personal, academic and intellectual issues.

    Any potential conflict of interest should be disclosed in the cover letter. Sources of outside support for research, including funding, equipment, and drugs, must be named in the cover letter. If an author has no conflicts of interest to declare, this must be explicitly stated. Authors should contact the Editorial Office with questions or concerns, but should err on the side of inclusion when in doubt. Manuscripts that fail to include the complete statements of all authors upon submission will be returned to the corresponding author and will delay the processing and evaluation of the manuscript.

    The JMIRS adheres to the policy on conflict of interest from the International Committee of Medical Journal Editors. If, in the editor's judgment, the information disclosed by the author represents a potential conflict of interest, it may be made available to reviewers and may be published at the editor's discretion; authors will be informed of the decision before publication. The editor will discuss with the authors on an individual basis the method by which any conflicts of interest will be communicated to readers. Editors and reviewers for the JMIRS are responsible for disclosing to the editor-in-chief any personal or financial relationship that may bias their work during the peer review process and recuse themselves when such conflicts are of sufficient.

    Statement of Informed Consent
    The patient's rights to privacy should not be infringed. Identifying information must be deleted from the text, figures and tables, unless it is essential for scientific purposes and the patient gives written informed consent for publication after being shown the manuscript to be published. Manuscripts containing the results of experimental studies on human participants must disclose in the first paragraph of the Materials and Methods section whether informed consent was obtained from patients in the study after the nature of the procedure had been fully explained. For further information on informed consent, see the International Committee of Medical Journal Editors.

    Ethical Considerations
    All experimental work with patients and volunteers must be carried out according to the Helsinki Declaration of 1975, as revised in 2000. For human subject data, a statement must be added to the "Methods" section indicating that an institutional review committee approved the study (with the date of approval) and that the subjects provided informed consent. For information on Ethics in Publishing and Ethical guidelines for journal publication, see the International Committee of Medical Journal Editors. All studies involving animals must state that the authors followed the guidelines for the use and care of laboratory animals of the author's institution or the National Research Council or any national law pertaining to animal research care.

    Authorship
    All authors should have made substantial contributions to all of the following: (1) conception and design of the study, or acquisition of data, or analysis and interpretation of data; (2) drafting the article or revising it critically for important intellectual content; and (3) final approval of the version to be submitted. Participation solely in the acquisition of funding or the collection of data does not justify authorship. General supervision of the research group does not justify authorship. Any part of an article critical to its main conclusions must be the responsibility of at least one author. Only those with key responsibility for the material in the article should be listed as authors; others contributing to the work should be recognized in the acknowledgement section. Manuscripts and all materials are received with the understanding that all authors have reviewed the submission and approve its submission for publication. The order of authorship must be agreed to by all co-authors before the manuscript is submitted for consideration. Any changes in authorship after submission of a manuscript must be explained in a letter to the editor-in-chief that is signed by all co-authors to indicate their consent to the change. These changes include the deletion and addition of authors as well as any change in the order of authors.

    Statistics
    The description of statistical procedures should be included in the section of Methods and Materials. Statistical methods should be clearly identified and described in sufficient detail for a knowledgeable reader to reproduce the analysis if they had access to the raw data. The choice of method should be motivated. When relevant, the statistical software used and its version number should be stated. The term 'significant' should be reserved for findings that are statistically significant at the 5% level. It should be stated whether P-values are from one- or two-sided tests. The JMIRS encourages the reporting of 95% confidence intervals rather than simple P-values whenever relevant. A special concern is the statistical power of analyses showing that a parameter is not significantly associated with the outcome, despite previous reports of a significant association. Here, a confidence interval should be estimated for the effect of this parameter as an indication of the statistical strength of the reported non-significance. Multivariate analyses should be reported with a clear indication of the criteria for selection of parameters to be tested in the model, and how these parameters were represented ('scored') in the model. This applies both for parameters significantly associated with the outcome parameter and parameters for which this is not so.

    Language / Spelling / Readability
    The JMIRS is an international journal and it is the aim of the editors to produce papers in clear and concise language. Brief sentences make for easy reading. The text in your manuscript should be easy to read and flow smoothly. A manuscript that is poorly structured, hard to reading and filled with errors is harder to review than one that is well written and where the ideas are presented clearly. Before submitting it for review, please be sure to check your manuscript carefully for structural, spelling and grammatical errors. You may wish to have it reviewed by a third party who has strong English writing and editing skills.Only standard abbreviations and acronyms should be used, and each one should be defined at its first use in the text. Excessive use of abbreviations should be avoided. Be sure that your manuscripts are free of spelling errors. Authors who require information about language editing and copyediting services pre- and post-submission should visit http://www.elsevier.com/languagepolishing for more information.

    Drug Names / Instrumentation Names
    Scientific (generic) names of drugs should be used when first cited, followed by (in parentheses) the trade (proprietary) name and the manufacturer and location (city/state/country) of the product. In subsequent mention in the article, the generic name should be used. Names of instruments should be followed by the manufacturer's name and location (city/state/country) in parentheses. In subsequent mention, only the name of the instrument should be used. In subsequent mention in the article, the generic name should be used.

    Colour
    If, together with your accepted article, you submit usable colour figures then Elsevier will ensure, at no additional charge, that these figures will appear in colour on the web (e.g., ScienceDirect and other sites) regardless of whether or not these illustrations are reproduced in colour in the printed version. Please make sure that artwork files are in an acceptable format (TIFF, EPS or MS Office files) and with the correct resolution. For colour reproduction in print, you will receive information regarding the total costs from Elsevier after receipt of your accepted article. For further information on the preparation of electronic artwork, please see http://www.elsevier.com/artworkinstructions. Please note: Because of technical complications that can arise from the conversion of colour figures to 'grey scale' (for the printed version should you not opt for colour in print) please submit in addition usable black and white prints corresponding to all the colour illustrations.

    Updated October 2011

Advertisement

advert image